We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+9.59%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$23.9B
AUM Growth
+$1.07B
(+4.7%)
Cap. Flow
-$810M
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.29%
Holding
2,206
New
135
Increased
803
Reduced
603
Closed
151
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$50M |
| 2 |
Truist Financial
TFC
|
+$40.3M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$39M |
| 4 |
Boston Scientific
BSX
|
+$32.9M |
| 5 |
Caterpillar
CAT
|
+$32.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$107M |
| 2 |
CELG
Celgene Corp
CELG
|
+$54.9M |
| 3 |
Palo Alto Networks
PANW
|
+$50.1M |
| 4 |
Molson Coors Class B
TAP
|
+$46.6M |
| 5 |
Apple
AAPL
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.2% |
| 2 | Financials | 16.88% |
| 3 | Healthcare | 13.3% |
| 4 | Communication Services | 9.11% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
1076
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $796K | ﹤0.01% |
12,800
-6,500
| -34% | -$309K |
|
1077
Charles River Laboratories
CRL
$10.9B
| $792K | ﹤0.01% |
5,188
+2,511
| +94% | +$348K |
|
1078
HealthEquity
HQY
$7.91B
| $792K | ﹤0.01% |
10,700
+900
| +9% | +$56.1K |
|
|
TBI
1079
Trueblue
TBI
$234M
| $791K | ﹤0.01% |
32,900
-3,100
| -9% | -$70.7K |
|
1080
Prosperity Bancshares
PB
$8.77B
| $790K | ﹤0.01% |
10,998
+5,582
| +103% | +$394K |
|
1081
Alaska Air
ALK
$5.15B
| $788K | ﹤0.01% |
11,643
-423,002
| -97% | -$28.9M |
|
1082
Madison Square Garden
MSGS
$9.54B
| $787K | ﹤0.01% |
3,755
+1,781
| +90% | +$349K |
|
1083
NetApp
NTAP
$32.9B
| $785K | ﹤0.01% |
12,611
-48
| -0.4% | -$2.8K |
|
1084
TD Synnex
SNX
$19.4B
| $785K | ﹤0.01% |
12,202
+4,736
| +63% | +$286K |
|
1085
Tenable Holdings
TENB
$3.56B
| $785K | ﹤0.01% |
32,800
+1,500
| +5% | +$36.5K |
|
1086
C.H. Robinson
CHRW
$22B
| $784K | ﹤0.01% |
10,027
+815
| +9% | +$64.9K |
|
|
MZTI
1087
The Marzetti Company
MZTI
$2.94B
| $784K | ﹤0.01% |
4,900
| – | – |
|
1088
Astec Industries
ASTE
$1.3B
| $781K | ﹤0.01% |
18,600
-3,400
| -15% | -$123K |
|
1089
JetBlue
JBLU
$1.96B
| $781K | ﹤0.01% |
41,766
+15,890
| +61% | +$295K |
|
|
STL
1090
DELISTED
Sterling Bancorp
STL
| $781K | ﹤0.01% |
37,055
+15,330
| +71% | +$313K |
|
1091
Primoris Services
PRIM
$4.69B
| $780K | ﹤0.01% |
35,100
+2,100
| +6% | +$45K |
|
|
RETA
1092
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $778K | ﹤0.01% |
3,810
+510
| +15% | +$93K |
|
1093
Avnet
AVT
$7.33B
| $777K | ﹤0.01% |
18,320
+9,272
| +102% | +$382K |
|
1094
Silicon Laboratories
SLAB
$7.15B
| $777K | ﹤0.01% |
6,700
| – | – |
|
1095
HEICO Corp
HEI
$48.9B
| $773K | ﹤0.01% |
6,779
+4,220
| +165% | +$519K |
|
1096
Enanta Pharmaceuticals
ENTA
$372M
| $772K | ﹤0.01% |
12,500
+700
| +6% | +$43.4K |
|
1097
Encompass Health
EHC
$11.2B
| $771K | ﹤0.01% |
+14,003
| New | +$760K |
|
|
PCH
1098
DELISTED
PotlatchDeltic
PCH
| $770K | ﹤0.01% |
17,816
| – | – |
|
|
CCF
1099
DELISTED
Chase Corporation
CCF
| $770K | ﹤0.01% |
6,500
-200
| -3% | -$23.2K |
|
|
NXGN
1100
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $769K | ﹤0.01% |
47,900
+9,700
| +25% | +$160K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q4 2019 Portfolio in Review
As of Q4 2019, STRS Ohio held 2,206 positions worth $23.9B, up 4.7% from $22.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
STRS Ohio withdrew a net $810M in Q4 2019, closing 151 positions and reducing 603 holdings. Its most notable exit was Celgene Corp, an estimated $54.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
Against the trend, STRS Ohio opened a new position in Everpure Inc worth $10.4M.
- STRS Ohio's largest Q4 2019 buy was Everpure Inc: 607,721 shares worth $10.4M.
- STRS Ohio added most to Johnson & Johnson in Q4 2019, an estimated $50M increase.
- STRS Ohio's biggest Q4 2019 reduction was iShares MSCI EAFE ETF, cutting an estimated $107M.
- STRS Ohio fully exited Celgene Corp in Q4 2019, selling an estimated $54.9M.
- STRS Ohio's ten largest holdings make up 19% of its $23.9B portfolio in Q4 2019.
- STRS Ohio opened 135 new positions and closed 151 in Q4 2019.
- STRS Ohio's portfolio value rose 4.7% quarter-over-quarter to $23.9B.
Based on STRS Ohio's 13F filing for Q4 2019, filed 24 Jan 2020.